Modulation of cell rounding and apoptosis in trigeminal neurinoma cells by protein phosphatase inhibitors

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 295-300

  Marushige, Keiji ^a   Marushige, Yasuko ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Calyculin A; Cell rounding; Ceramide; Okadaic acid; Orthovanadate; Pervanadate; Trigeminal neurinoma

Indexed keywords

CALYCULIN A; CERAMIDE; ORTHOVANADIC ACID; PERVANADATE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; TRYPAN BLUE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SHAPE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INHIBITION; NEURINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRIGEMINAL NERVE;

ANIMALS; APOPTOSIS; CERAMIDES; ENZYME INHIBITORS; NEURILEMMOMA; OXAZOLES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEINS; RATS; TRIGEMINAL NERVE; TUMOR CELLS, CULTURED; VANADATES;

EID: 0031924002     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Meredith JE Jr, Fazeli B and Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 4: 953-961, 1993.
2. Frisch SM and Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626, 1994.
3. 1-induced apoptosis. Anticancer Res 15: 267-272, 1995.
4. Obeid LM, Linardic CM, Karolak LA and Hannum YA: Programmed cell death induced by ceramide. Science 259: 1769-1771, 1993.
5. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA and Grant S: Induction of apoptotic DNA damage and cell death by activation of sphingomyelin pathway. Proc Natl Acad Sei USA 91: 73-77, 1994.
6. Haimovitz-Friedman A, Kan C-C, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z and Kolesnick RN: Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180: 525-535, 1994.
7. Marushige Y, Marushige K and Koestner A: Growth inhibition of synchronized trigeminal neurinoma cells by nerve growth factor. Anticancer Res 14: 153-156, 1994.
8. 1 in glioma and trigeminal neurinoma cells. Anticancer Res 14: 2419-2424, 1994.
9. Zhao Z, Tan Z, Diltz CD, You M and Fischer EH: Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem 271: 22251-22255, 1996.
10. Posner BJ, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS and Shaver A: Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 269: 4596-4604, 1994.
11. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D and Hartshorne DJ: Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159: 871-877, 1989.
12. Martin SJ and Green DR: Protease activation during apoptosis: Death by a thousand cuts? Cell 82: 349-352, 1995.
13. Marushige Y and Marushige K: Alterations of focal adhesion and cytoskeletal proteins during apoptosis. Anticancer Res 18: 301-308, 1998.
14. Belizario JE and Dinarello CA: Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor β increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle. Cancer Res 51: 2379-2385, 1991.
15. Meikrantz W, Gisselbrecht S, Tam SW and Schlegel R: Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 91: 3754-3758, 1994.
16. Parks DS, Farinnelli SE and Greene LA: Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J Bio Chem 271: 8161-8169, 1996.
17. Meikrantz W and Schlegel R: Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem 271: 10205-10209, 1996.
18. Maher PA, Pasquale EB, Wang JYJ and Singer SJ: Phosphotyrosine-containing proteins are concentrated in focal adhesions and intercellular junctions in normal cells. Proc Natl Acad Sci USA 82: 6576-6580, 1985.
19. Burridge K and Chrzanowska-Wodnicka M: Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12: 463-518, 1996.
20. Yousefi S, Green DR, Blaser K and Simon H-W: Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci USA 91: 10868-10872, 1994.
21. Yang C, Chang J, Gorospe M and Passaniti A: Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation. Cell Growth and Differentiation 7: 161-171, 1996.
22. Gardner AM and Johnson GL: Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 271: 14560-14566, 1996.
23. Eriksson JE, Brautigan DL, Vallee R, Olmsted J, Fujiki H and Goldman RD: Cytoskeletal integrity in interphase cells requires protein Phosphatase activity. Proc Natl Acad Sci USA 89: 11093-11097, 1992.
24. Baxter GD and Lavin MF: Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shocks in human lymphoid tumor lines. J Immunol 148: 1949-1954, 1992.
25. Song Q and Lavin MF: Calyculin A, a potent inhibitor of phosphatase-1 and -2A, prevent apoptosis. Biochem Biophys Res Commun 190: 47-55, 1993.
26. Dou PP, An B and Will PL: Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc Natl Acad Sci USA 92: 9019-9023, 1995.
27. Morana SJ, Wolf CM, Li J, Reynolds JE, Brown MK and Eastman A: The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis. J Biol Chem 271: 18263-18271, 1996.
28. Gjertsen B and Døskeland SO: Protein phosphorylation in apoptosis. Biochim Biophys Acta 1269: 187-199, 1995.